Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Schizophrenia and diabetes: epidemiological data.

F Rouillon1, F Sorbara

  • 1Service de psychiatric adulte and Inserm U513, hôpital Sainte-Anne, 1, rue Cabanis, 75014 Paris, France. jd.guelfi@ch-sainte-anne.fr

European Psychiatry : the Journal of the Association of European Psychiatrists
|February 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Follow-up study of patients treated with olanzapine pamoate in France in real-life treatment situation.

L'Encephale·2017
Same author

Attention-deficit/hyperactivity disorder symptoms and psychological comorbidity in eating disorder patients.

Eating and weight disorders : EWD·2017
Same author

[Reflection on the psychiatric financial allocation in France].

L'Encephale·2016
Same author

Alcohol Consumption: the Burden of Entourage.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

[Vigilance level for cardiovascular risk factors in schizophrenic patients].

L'Encephale·2015
Same author

Depression comorbid with anxiety or medical illness: The role of paroxetine.

International journal of psychiatry in clinical practice·2014
Same journal

Predictors of Conversion from Major Depressive Disorder to Bipolar Disorder: A Population-Based PADRIS-PRESTO Cohort Study in Catalonia.

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same journal

Precision medicine in mental health: applications, challenges, and recommendations - CORRIGENDUM.

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same journal

Real-world effectiveness and safety of intranasal esketamine for treatment-resistant depression: data from the enTRD registry.

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same journal

Trajectory of response to esketamine nasal spray for treatment resistant depression: findings from ESCAPE-TRD.

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same journal

Identification of distinct clinical phenotypes and their neurobiological signatures in stress-exposed individuals: A multimodal machine learning approach.

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same journal

The interplay among narcissistic vulnerability, interpersonal sensitivity, and metacognitive integration: A network analysis approach.

European psychiatry : the journal of the Association of European Psychiatrists·2026
See all related articles

People with schizophrenia have a 1.5-2 times higher risk of developing diabetes mellitus. This increased risk is linked to lifestyle, genetics, and antipsychotic medications, requiring further research.

Area of Science:

  • Psychiatry
  • Endocrinology
  • Epidemiology

Background:

  • The link between diabetes mellitus and schizophrenia has been observed for over a century.
  • Epidemiological studies indicate a 1.5-2 times higher prevalence of diabetes in schizophrenia patients compared to the general population, especially in younger individuals.

Purpose of the Study:

  • To explore the multifactorial reasons behind the increased prevalence of diabetes mellitus in patients with schizophrenia.
  • To review potential environmental, biological, and medication-related factors contributing to this association.

Main Methods:

  • Review of epidemiological studies and familial data.
  • Discussion of proposed biological mechanisms (neuroendocrine, neurodevelopmental).
  • Examination of the potential role of antipsychotic medications in diabetes risk.

Related Experiment Videos

Main Results:

  • Schizophrenia patients exhibit significantly higher rates of diabetes.
  • Both lifestyle factors (sedentary behavior, poor diet) and a potential heritable component contribute to the risk.
  • Antipsychotic medication is a suspected factor, though its precise role and drug-specific risks require further investigation.

Conclusions:

  • The elevated risk of diabetes in schizophrenia is likely due to a combination of environmental, genetic, and pharmacological factors.
  • Further research is essential to clarify the specific contributions of antipsychotic drugs to glycemic control issues in this population.